Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.03 USD
Change Today -0.0005 / -1.43%
Volume 7.9M
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

cannabis science inc (CBIS) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/14 - $0.13
52 Week Low
04/17/15 - $0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CANNABIS SCIENCE INC (CBIS)

cannabis science inc (CBIS) Related Bloomberg News

View More Bloomberg News

cannabis science inc (CBIS) Related Businessweek News

No Related Businessweek News Found

cannabis science inc (CBIS) Details

Cannabis Science, Inc. develops, produces, and commercializes phytocannabinoid-based pharmaceutical products. It develops medicines to treat autism, blood pressure, cancer, and cancer side effects, as well as other illnesses, including general health maintenance. The company is developing CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as for those intolerant of available therapies; CS-S/BCC-1 for basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, it provides an online video-based medical cannabis education system comprising various courses, such as medical cannabis law, medical marijuana, cooking, horticulture, and bud tending. The company has a license agreement with Apothecary Genetics Investments LLC. to produce various brand formulations for California medical cannabis market. Cannabis Science, Inc. is based in Colorado Springs, Colorado.

cannabis science inc (CBIS) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: --
Co-Founder, Chief Operating Officer, General ...
Total Annual Compensation: $60.0K
Chief Financial Officer and Director
Total Annual Compensation: $30.0K
President of European Operations and Director
Total Annual Compensation: $22.5K
Chief Scientific Officer
Total Annual Compensation: $22.0K
Compensation as of Fiscal Year 2013.

cannabis science inc (CBIS) Key Developments

Cannabis Science, Inc. Auditor Raises 'Going Concern' Doubt

Cannabis Science, Inc. filed its 10-K on Apr 21, 2015 for the period ending Dec 31, 2014. In this report its auditor, Turner, Stone & Company, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Cannabis Science, Inc. announced delayed annual 10-K filing

On 04/01/2015, Cannabis Science, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Cannabis Science Names Derwin A. Wallace to Head its Investor Relations Initiatives

Cannabis Science, Inc. announced that it has entered into a one-year agreement with Derwin A. Wallace to provide financial and investor relations services for the company. Mr. Wallace will focus on developing and expanding the company's financial communications with the institutional and retail investment communities and initiate coverage from research analysts through a comprehensive financial and investor relations program. Prior to contracting with Cannabis Science, Mr. Wallace accumulated more than 15 years of investor relations experience at companies including Home Depot, Cox Cable, First Data, and ResCare. As an investor relations professional, Mr. Wallace has extensive experience communicating with and educating institutional investors, retail investors and research analysts, including those interested in the medical cannabis industry.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBIS:US $0.03 USD -0.0005

CBIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GW Pharmaceuticals PLC 596.00 GBp -3.00
Medical Marijuana Inc $0.08 USD -0.0008
PharmaCyte Biotech Inc $0.15 USD -0.0026
View Industry Companies

Industry Analysis


Industry Average

Valuation CBIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 37,954.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANNABIS SCIENCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at